Graft vs Host Disease

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

Horizons Chronic Graft-Versus-Host-Disease Study

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression

Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Evaluation of the Impact of Reduced Immunosuppression

Chronic GVHD Response Measures Validation

Pediatric cGVHD Symptom Scale

Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

Optoacoustic Detection of Inflammation Using MSOT Device

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Fatigue and Cognitive Dysfunction Due to Synaptopathy or Graft Versus Host (GVH) Disease in the Brain.